NeurAxis, Inc. (NRXS)Healthcare | Biotechnology | Carmel, United States | NYSE American
7.22 USD
-0.14
(-1.902%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 7.45 +0.23 (3.157%) ⇧ (April 17, 2026, 7:55 p.m. EDT) Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 12:58 a.m. EDT
While short-term momentum is driven by a strong revenue beat (27.2% growth) and positive prediction models (39% upward bias), the bullish thesis is severely compromised by negative free cash flow (-$3.8M), negative operating leverage, and a 'preferred stock dividend' that represents capital return via equity dilution rather than sustainable cash profit. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.068532 |
| MSTL | 0.228897 |
| AutoARIMA | 0.232127 |
| AutoETS | 0.232648 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.21 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.452 |
| Excess Kurtosis | -0.72 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 12.55 |
| Revenue per Share | 0.393 |
| Market Cap | 80,774,752 |
| Forward P/E | -361.00 |
| Beta | 1.89 |
| Profit Margins | -218.55% |
| Website | https://neuraxis.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 3.022284 |
| Address1 | 11,611 North Meridian St |
| Address2 | Suite 330 |
| All Time High | 7.97 |
| All Time Low | 1.33 |
| Ask | 7.42 |
| Ask Size | 500 |
| Average Daily Volume10 Day | 142,640 |
| Average Daily Volume3 Month | 150,174 |
| Average Volume | 150,174 |
| Average Volume10Days | 142,640 |
| Beta | 1.888 |
| Bid | 7.3 |
| Bid Size | 200 |
| Book Value | 0.319 |
| City | Carmel |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.22 |
| Current Ratio | 2.053 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 7.38 |
| Day Low | 6.92 |
| Debt To Equity | 12.55 |
| Display Name | NeurAxis |
| Ebitda | -7,139,839 |
| Ebitda Margins | -2.00036 |
| Enterprise To Ebitda | -10.678 |
| Enterprise To Revenue | 21.36 |
| Enterprise Value | 76,240,088 |
| Eps Current Year | -0.54 |
| Eps Forward | -0.02 |
| Eps Trailing Twelve Months | -0.95 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.2764 |
| Fifty Day Average Change | 0.9435997 |
| Fifty Day Average Change Percent | 0.15034091 |
| Fifty Two Week Change Percent | 302.2284 |
| Fifty Two Week High | 7.97 |
| Fifty Two Week High Change | -0.75 |
| Fifty Two Week High Change Percent | -0.09410289 |
| Fifty Two Week Low | 1.55 |
| Fifty Two Week Low Change | 5.67 |
| Fifty Two Week Low Change Percent | 3.6580646 |
| Fifty Two Week Range | 1.55 - 7.97 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,691,587,800,000 |
| Float Shares | 7,524,023 |
| Forward Eps | -0.02 |
| Forward P E | -361.0 |
| Free Cashflow | -3,857,785 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 24 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.84229 |
| Gross Profits | 3,006,366 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.23608999 |
| Held Percent Institutions | 0.22797 |
| Implied Shares Outstanding | 11,187,639 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana. |
| Long Name | NeurAxis, Inc. |
| Market | us_market |
| Market Cap | 80,774,752 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1789827517 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -8,615,152 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 80,774,753 |
| Number Of Analyst Opinions | 2 |
| Open | 7.4 |
| Operating Cashflow | -6,432,843 |
| Operating Margins | -1.77339 |
| Payout Ratio | 0.0 |
| Phone | 812 689 0791 |
| Post Market Change | 0.22790003 |
| Post Market Change Percent | 3.15651 |
| Post Market Price | 7.4479 |
| Post Market Time | 1,776,470,107 |
| Previous Close | 7.36 |
| Price Eps Current Year | -13.37037 |
| Price Hint | 2 |
| Price To Book | 22.633228 |
| Price To Sales Trailing12 Months | 22.630533 |
| Profit Margins | -2.1854699 |
| Quick Ratio | 1.848 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.14 |
| Regular Market Change Percent | -1.90218 |
| Regular Market Day High | 7.38 |
| Regular Market Day Low | 6.92 |
| Regular Market Day Range | 6.92 - 7.38 |
| Regular Market Open | 7.4 |
| Regular Market Previous Close | 7.36 |
| Regular Market Price | 7.22 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 228,882 |
| Return On Assets | -0.80626 |
| Return On Equity | -2.85362 |
| Revenue Growth | 0.272 |
| Revenue Per Share | 0.393 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,187,639 |
| Shares Percent Shares Out | 0.0162 |
| Shares Short | 181,362 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 127,259 |
| Short Name | Neuraxis, Inc. |
| Short Percent Of Float | 0.0212 |
| Short Ratio | 0.83 |
| Source Interval | 15 |
| State | IN |
| Symbol | NRXS |
| Target High Price | 13.0 |
| Target Low Price | 9.0 |
| Target Mean Price | 11.0 |
| Target Median Price | 11.0 |
| Total Cash | 4,965,072 |
| Total Cash Per Share | 0.444 |
| Total Debt | 426,610 |
| Total Revenue | 3,569,282 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.95 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.859145 |
| Two Hundred Day Average Change | 3.3608549 |
| Two Hundred Day Average Change Percent | 0.8708807 |
| Type Disp | Equity |
| Volume | 228,882 |
| Website | https://neuraxis.com |
| Zip | 46,032 |